These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26159742)

  • 21. Directly acting antivirals for hepatitis C virus arrive in HIV/hepatitis C virus co-infected patients: from 'mind the gap' to 'where's the gap?'.
    Childs K; Taylor C; Dieterich D; Agarwal K
    AIDS; 2016 Apr; 30(7):975-89. PubMed ID: 26836785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C in HIV-infected patients: impact of direct-acting antivirals.
    Bichoupan K; Dieterich DT
    Drugs; 2014 Jun; 74(9):951-61. PubMed ID: 24866024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.
    Rockstroh JK; Bhagani S
    BMC Med; 2013 Nov; 11():234. PubMed ID: 24228933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimum combination therapy regimens for HIV/HCV infection.
    Rey D; Muret P; Piroth L
    Expert Rev Anti Infect Ther; 2016; 14(3):299-309. PubMed ID: 26822803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD
    Clin Infect Dis; 2015 Oct; 61(7):1127-34. PubMed ID: 26060286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management and treatment of chronic hepatitis C in HIV patients.
    Barreiro P; Vispo E; Labarga P; Soriano V
    Semin Liver Dis; 2012 May; 32(2):138-46. PubMed ID: 22760653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2010 Jun; 65(6):1079-85. PubMed ID: 20335191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New hepatitis C therapies for special patient populations.
    Soriano V; Labarga P; de Mendoza C; Fernández-Montero JV; Esposito I; Benítez-Gutiérrez L; Peña JM; Barreiro P
    Expert Opin Pharmacother; 2016; 17(2):217-29. PubMed ID: 26595348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens.
    Chen TY; Jain MK
    AIDS Patient Care STDS; 2015 Jun; 29(6):329-37. PubMed ID: 26020726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct-acting antiviral-based therapy for acute hepatitis C coinfection.
    Boesecke C; Page E
    Curr Opin HIV AIDS; 2015 Sep; 10(5):330-6. PubMed ID: 26248120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
    Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
    AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV-HIV co-infected patients: no longer a 'special' population?
    Sulkowski MS
    Liver Int; 2016 Jan; 36 Suppl 1():43-6. PubMed ID: 26725896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals?
    de Mendoza C
    AIDS Rev; 2016; 18(2):112-3. PubMed ID: 27232507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How will we manage acute HCV in men having sex with men in the era of all oral therapy?
    Boesecke C; Rockstroh JK
    J Viral Hepat; 2015 Jan; 22(1):2-7. PubMed ID: 25333810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG; Chung RT
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards hepatitis C eradication from the HIV-infected population.
    Barreiro P; Fernandez-Montero JV; de Mendoza C; Labarga P; Soriano V
    Antiviral Res; 2014 May; 105():1-7. PubMed ID: 24534673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
    Bichoupan K; Dieterich DT; Martel-Laferrière V
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):241-9. PubMed ID: 24996617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
    Seden K; Back D
    Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.